Skip to main content

Table 3 Comparing two groups (hematoma expansion group–non hematoma expansion group) in term of qualitative variables

From: Baseline neutrophil–lymphocyte ratio can be associated with hematoma expansion in patients with intracerebral hemorrhage: a retrospective observational study

Variable Hematoma expansion Statistical test
Yes (n = 57) No (n = 164)
Gender
 Male 33 (27.7) 89 (72.3) P = 0.643
 Female 24 (24.2) 75 (76.8)
Hypertension
 Yes 31 (23.3) 102 (76.69) P = 0.321
 No 26 (29.5) 62 (70.5)
Diabetes
 Yes 16 (26.6) 44 (73.4) P = 0.508
 No 41 (25.4) 120 (74.5)
Smoking
 Yes 14 (22.2) 49 (77.8) P = 0.754
 No 43 (27.2) 115 (72.8)
Hematoma location
 Lobar 28 (28.3) 71 (71.7) P = 0.866
 Deep 17 (23.9) 54 (76.1)
 Cerebellar 7 (21.2) 26 (78.8)
 Brain stem 5 (27.7) 13 (72.2)
GOS
 Unfavorable outcome
  Death 14 (30.4) 32 (69.6) P = 0.017
  Vegetative state 7 (28) 18 (72)
  Sever disability 13 (26.5) 36 (73.5)
 Favorable outcome
  Moderate disability 14 (22.9) 47 (77.1)
  Good recovery 9 (22.5) 31 (77.5)
Need for surgery
 Yes 28 (43.7) 36 (56.3) P = 0.011
 No 29 (18.4) 128 (81.6)
Intera-ventricular hemorrhage
 Yes 12 (25.0) 36 (75.0) P = 0.210
 No 45 (26.0) 128 (74.0)
Hydrocephalus
 Yes 7 (22.5) 24 (77.5) P = 0.625
 No 50 (26.3) 140 (73.7)
  1. Bold indicates p < 0.05
  2. GOS Glasgow Outcome Scale